Naples PCI Registry

Condition(s) studied

Investigational drug(s) / intervention(s)

PCI: Percutaneous coronary intervention

Study summary

The aim of the Naples PCI registry is to collect prospective data on baseline clinical, laboratory, and angiographic characteristics of patients undergoing PCI for acute or chronic coronary artery disease. All patients receive clinical follow-up at hospital discharge and at 1-year follow-up with the objective to assess clinical outcomes, including death, cardiovascular death, myocardial infarction, stroke, stent thrombosis, target-lesion and target-vessel revascularization, contrast-induced acute kidney injury, and bleeding events.

Eligibility

Primary outcome measure(s)

• Number of patients with death — 12 months
  Death
• Number of patients with myocardial infarction — 12 months
  Myocardial infarction
• Number of patients with stroke — 12 months
  Stroke
• Number of patients with stent thrombosis — 12 months
  Stent thrombosis
• Number of patients with target-vessel revascularization — 12 months
  Target vessel revascularization
• Number of patients with target-lesion revascularization — 12 months
  Target lesion revascularization
• Number of patients with contrast-induced acute kidney injury — 12 months
  Contrast-induced acute kidney injury
• Number of patients with bleeding — 12 months
  Bleeding

Trial sites (1)

More Federico II University trials in Italy

Other trials for the same condition